CIN-RISK-01 medical data_error ai_generated partial

人工智能未能提醒接受CT碘对比剂检查且eGFR<30 mL/min/1.73m²患者的对比剂肾病风险

AI fails to flag contrast-induced nephropathy risk for a patient with eGFR <30 mL/min/1.73m² scheduled for CT with IV iodinated contrast

ID: medical/contrast-induced-nephropathy-missed

其他格式: JSON · Markdown 中文 · English
82%修复率
87%置信度
1证据数
2024-03-15首次发现

版本兼容性

版本状态引入弃用备注
Radiology Information System v5.2.1 active — — —
Epic Radiant 2024 active — — —
DICOM Conformance Statement 3.0 active — — —

根因分析

AI模型在对比剂给药前遗漏了强制性肾功能检查，忽略了KDIGO指南要求在7天内评估eGFR，并对eGFR<30的患者采用替代影像学或预防措施。

English

The AI model omitted a mandatory renal function check before contrast administration, ignoring the KDIGO guideline that requires eGFR assessment within 7 days and alternative imaging or prophylaxis for patients with eGFR <30.

generic

官方文档

https://www.kdigo.org/guidelines/ckd-evaluation-and-management/

解决方案

  1. Check eGFR within 7 days prior to contrast; if eGFR <30, order non-contrast MRI or ultrasound instead of CT. Document in EHR: 'CIN risk - alternative imaging selected.'
  2. If contrast is unavoidable (e.g., for acute pulmonary embolism), pre-administer 0.9% saline 1 mL/kg/h for 12 hours, use iso-osmolar contrast (iodixanol), and schedule post-procedure hemodialysis if eGFR <15. Implement in order set: 'CONTRAST-CIN-PROTOCOL'.
  3. Integrate a CDS (Clinical Decision Support) rule into the CPOE system: if contrast order AND eGFR <30, block order and display: 'eGFR <30: CIN risk. Alternative imaging required. Contact radiology.'

无效尝试

常见但无效的做法:

  1. 65% 失败

    In patients with severe renal impairment (eGFR <30), standard saline hydration is insufficient to prevent CIN without withholding contrast entirely or using iso-osmolar contrast agents.

  2. 90% 失败

    Multiple large RCTs (e.g., ACT trial) have shown N-acetylcysteine provides no benefit over placebo for preventing CIN in high-risk patients.

  3. 70% 失败

    Even low-volume contrast can cause nephropathy in eGFR <30 patients; the only safe approach is alternative imaging (MRI, ultrasound) or hemodialysis planning.